ArticleACS nano2025
Multiplexed Nanoscale Viscoelastic Mapping at Multiple Time Scales of Melanoma Cells as a Label-Free Cancer Biomarker.
Article in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Advances in nanomechanical property mapping by atomic force microscopy.Nanoscale advances · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Evaluating nanoscale cellular mechanics for disease biomarkers has been challenging due to the significant heterogeneity between cells and other biological structures, which reflects the variability in gene expression. Atomic force microscopy-based methods can visualize these heterogeneities with high spatiotemporal resolution; however, processing large time-dependent viscoelastic data sets is computationally expensive. Here, we introduce a novel viscoelastic method based on a modified Fourier transform, enabling multitime-scale viscoelastic analysis at drastically improved rates (over 37,386-fold) compared to traditional approaches. We used this method to quantify multitime-scale viscoelastic properties of living melanoma cells with varying degrees of malignancy. More malignant cells are softer and more fluid near the nucleus, while the leading edge is stiffer and more viscous, suggesting that regional mechanical effects are critical for enhanced migration. Cellular population heterogeneity analyses revealed that metastatic cells exhibit fluid-like viscoelastic behavior, while benign cells exhibit more solid-like behavior. This new method provides novel label-free biophysical indicators to aid in diagnostic and therapeutic approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.